Výsledky vyhledávání - "Marjane, Ertault"

Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients

Autor: Catherine Thieblemont, Marjane Ertault, Patricia Franchi, Cédric de Bazelaire, Eric de Kerviler, Josette Brière, Nathalie Beranger, Chadi Al Nawakil, Pauline Brice, David Sibon

Publikováno v: British Journal of Haematology. 153:191-198

Summary Around 20% of Hodgkin lymphoma (HL) patients are refractory to first-line therapy with ABVD (adriamycin–bleomycin–vinblastine–dacarbazine) or relapse after complete remission. Salvage regimens frequently have delayed courses or require

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4c29c00389af048241d6422460c03ffc
https://doi.org/10.1111/j.1365-2141.2011.08594.x

Zobrazit plný text záznamu

Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients

Autor: David, Sibon, Marjane, Ertault, Chadi, Al Nawakil, Cédric, de Bazelaire, Patricia, Franchi, Josette, Brière, Eric, de Kerviler, Nathalie, Beranger, Catherine, Thieblemont, Pauline, Brice

Publikováno v: British journal of haematology. 153(2)

Around 20% of Hodgkin lymphoma (HL) patients are refractory to first-line therapy with ABVD (adriamycin-bleomycin-vinblastine-dacarbazine) or relapse after complete remission. Salvage regimens frequently have delayed courses or require dose-reduction

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::37c9bade2948bd0d95b029c522736fd2
https://pubmed.ncbi.nlm.nih.gov/21385169

Zobrazit plný text záznamu

Long term hematologic recovery after autologous stem cell transplantation in lymphoma patients: impact of the number of prefreeze and post-thaw CD34+ cells

Autor: Nicolas, Mounier, Jérome, Larghero, Julien, Manson, Pauline, Brice, Isabelle, Madelaine-Chambrin, Josette, Brière, Marjane, Ertault, Christophe, Hennequin, Jean-Michel, Miclea, Marc, Benbunan, Jean-Pierre, Marolleau, Christian, Gisselbrecht

Publikováno v: Bulletin du cancer. 92(3)

Autologous Stem Cell Transplantation (ASCT) with Peripheral Blood Stem Cells is widely used as consolidation in lymphoma patients. The rapidity and stability of cell engraftment correlate with the number of CD34+ cells in the autograft. However, whet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0e51c105588b467f8a5e49d0d650f7ef
https://pubmed.ncbi.nlm.nih.gov/15820915

Zobrazit plný text záznamu

Efficacy and toxicity of two schedules of R-CHOP plus bortezomib in front-line B lymphoma patients: A randomized phase II trial from the Groupe d’Etude des Lymphomes de l’Adulte (GELA)

Autor: Vincent Ribrag, Christophe Fermé, E. De Kerviler, Corinne Haioun, Jean Baptiste Golfier, Nicolas Mounier, Pauline Brice, Josette Brière, Christian Gisselbrecht, Gilles Salles, Marjane Ertault

Publikováno v: Journal of Clinical Oncology. 25:8010-8010

8010 Background: Bortezomib is the first proteasome inhibitor that showed promising activity in hematologic malignancies. In Jan 2005, we initiated a phase II randomized trial to evaluate front-line R-CHOP + bortezomib in B lymphoma pts. Methods: 6 c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7156d56e2e0085f70e2584309a59b768
https://doi.org/10.1200/jco.2007.25.18_suppl.8010

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání